<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>MDS CAST</title>
    <link>http://www.lls.org</link>
    <description>Podcast for those living with Myelodysplastic Syndromes (MDS). Sponsored by The Leukemia &amp; Lymphoma Society</description>
    <copyright>(c)2008</copyright>
    <managingEditor>admin@lls.org (admin@lls.org)</managingEditor>
    <language>en-us</language>
    <lastBuildDate>Mon, 20 May 2013 22:00:10 GMT</lastBuildDate>
    <generator>Hipcast RSS Feeder 1.25</generator>
    <category>Health &amp; Fitness</category>
    <atom:link href="http://lls.hipcast.com/rss/mdscast.xml" rel="self" type="application/rss+xml"/>
    <ttl>60</ttl>
    <image>
      <url>http://lls.hipcast.com/albumart/1009.1369087210.jpg</url>
      <link>http://www.lls.org</link>
      <title>MDS CAST</title>
    </image>
    <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
    <itunes:summary>Podcast for those living with Myelodysplastic Syndrome (MDS). Sponsored by The Leukemia &amp; Lymphoma Society</itunes:summary>
    <itunes:subtitle></itunes:subtitle>
    <itunes:explicit>no</itunes:explicit>
    <itunes:keywords>myelodysplastic,mds,cancer</itunes:keywords>
    <itunes:owner>
      <itunes:name>Samantha Mills</itunes:name>
      <itunes:email>admin@leukemia-lymphoma.org</itunes:email>
    </itunes:owner>
    <itunes:image href="http://lls.hipcast.com/albumart/1009.1369087210.jpg"/>
    <itunes:category text="Health"/>
    <itunes:category text="Science &amp; Medicine">
      <itunes:category text="Medicine"/>
    </itunes:category>
    <item>
      <guid isPermaLink="false">230df4c5-6d86-681d-5aaf-39cdb777c8c7</guid>
      <title>MDS - Diagnosis and Treatment Update - Part 1</title>
      <description><![CDATA[Date: March 12, 2013
 
Speaker: Gail J. Roboz, MD
 
Topics Covered:
 Myelodysplastic syndromes (MDS) 
Diagnostic tests for MDS 
Factors used to develop a plan for treatment 
Current and emerging therapies for MDS 
Possible treatment side effects and management 
The role of clinical trials in the advancement of MDS treatment for 
patients]]></description>
      <pubDate>Fri, 12 Apr 2013 18:37:39 GMT</pubDate>
      <itunes:duration>00:32:01</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Date: March 12, 2013&#13;
 &#13;
Speaker: Gail J. Roboz, MD&#13;
 &#13;
Topics Covered:&#13;
 Myelodysplastic syndromes (MDS) &#13;
Diagnostic tests for MDS &#13;
Factors used to develop a plan for treatment &#13;
Current and emerging therapies for MDS &#13;
Possible treatment side effects and management &#13;
The role of clinical trials in the advancement of MDS treatment for &#13;
patients</itunes:summary>
      <itunes:subtitle>MDS - Diagnosis and Treatment Update - Part 1</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/da740944-878e-134d-0169-5f32df06767a.mp3" type="audio/mpeg" length="7690459"/>
      <media:title>MDS - Diagnosis and Treatment Update - Part 1</media:title>
      <media:text type="plain">Date: March 12, 2013&#13;
 &#13;
Speaker: Gail J. Roboz, MD&#13;
 &#13;
Topics Covered:&#13;
 Myelodysplastic syndromes (MDS) &#13;
Diagnostic tests for MDS &#13;
Factors used to develop a plan for treatment &#13;
Current and emerging therapies for MDS &#13;
Possible treatment side effects and management &#13;
The role of clinical trials in the advancement of MDS treatment for &#13;
patients</media:text>
      <media:content url="http://lls.hipcast.com/deluge/da740944-878e-134d-0169-5f32df06767a.mp3" type="audio/mpeg" fileSize="7690459" duration="1921"/>
      <link>http://lls.hipcast.com/deluge/da740944-878e-134d-0169-5f32df06767a.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">440613ce-d0d6-685f-5f5f-4850c7d9b891</guid>
      <title>MDS - Diagnosis and Treatment Update - Part 2</title>
      <description><![CDATA[Date: March 12, 2013
 
Speaker: Gail J. Roboz, MD
 
Topics Covered:
 Myelodysplastic syndromes (MDS) 
Diagnostic tests for MDS 
Factors used to develop a plan for treatment 
Current and emerging therapies for MDS 
Possible treatment side effects and management 
The role of clinical trials in the advancement of MDS treatment for 
patients]]></description>
      <pubDate>Fri, 12 Apr 2013 18:36:41 GMT</pubDate>
      <itunes:duration>00:26:14</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Date: March 12, 2013&#13;
 &#13;
Speaker: Gail J. Roboz, MD&#13;
 &#13;
Topics Covered:&#13;
 Myelodysplastic syndromes (MDS) &#13;
Diagnostic tests for MDS &#13;
Factors used to develop a plan for treatment &#13;
Current and emerging therapies for MDS &#13;
Possible treatment side effects and management &#13;
The role of clinical trials in the advancement of MDS treatment for &#13;
patients</itunes:summary>
      <itunes:subtitle>MDS - Diagnosis and Treatment Update - Part 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/be91d453-378c-01b5-b704-6ad0ad2aad9d.mp3" type="audio/mpeg" length="6300150"/>
      <media:title>MDS - Diagnosis and Treatment Update - Part 2</media:title>
      <media:text type="plain">Date: March 12, 2013&#13;
 &#13;
Speaker: Gail J. Roboz, MD&#13;
 &#13;
Topics Covered:&#13;
 Myelodysplastic syndromes (MDS) &#13;
Diagnostic tests for MDS &#13;
Factors used to develop a plan for treatment &#13;
Current and emerging therapies for MDS &#13;
Possible treatment side effects and management &#13;
The role of clinical trials in the advancement of MDS treatment for &#13;
patients</media:text>
      <media:content url="http://lls.hipcast.com/deluge/be91d453-378c-01b5-b704-6ad0ad2aad9d.mp3" type="audio/mpeg" fileSize="6300150" duration="1574"/>
      <link>http://lls.hipcast.com/deluge/be91d453-378c-01b5-b704-6ad0ad2aad9d.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">aa748717-dfd9-b1cb-661b-61922e83e68b</guid>
      <title>Blood Cancer Treatment - Making Informed Choices - Part 1</title>
      <description><![CDATA[Date: February 26, 2013

Speaker: Stephen D. Nimer, MD

Topics:
Understanding goals of treatment for your diagnosis
Understanding your treatment options
Benefits and risks for standard treatments and investigational treatments
Key facts about clinical trials]]></description>
      <pubDate>Fri, 05 Apr 2013 20:28:04 GMT</pubDate>
      <itunes:duration>00:40:24</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Date: February 26, 2013&#13;
&#13;
Speaker: Stephen D. Nimer, MD&#13;
&#13;
Topics:&#13;
Understanding goals of treatment for your diagnosis&#13;
Understanding your treatment options&#13;
Benefits and risks for standard treatments and investigational treatments&#13;
Key facts about clinical trials</itunes:summary>
      <itunes:subtitle>Blood Cancer Treatment - Making Informed Choices - Part 1</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/90f6f90f-8cb8-c292-8f35-031af4837b4d.mp3" type="audio/mpeg" length="9697545"/>
      <media:title>Blood Cancer Treatment - Making Informed Choices - Part 1</media:title>
      <media:text type="plain">Date: February 26, 2013&#13;
&#13;
Speaker: Stephen D. Nimer, MD&#13;
&#13;
Topics:&#13;
Understanding goals of treatment for your diagnosis&#13;
Understanding your treatment options&#13;
Benefits and risks for standard treatments and investigational treatments&#13;
Key facts about clinical trials</media:text>
      <media:content url="http://lls.hipcast.com/deluge/90f6f90f-8cb8-c292-8f35-031af4837b4d.mp3" type="audio/mpeg" fileSize="9697545" duration="2424"/>
      <link>http://lls.hipcast.com/deluge/90f6f90f-8cb8-c292-8f35-031af4837b4d.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">a4ed1e5f-a086-ba04-e6ab-9c7adb838b34</guid>
      <title>Blood Cancer Treatment - Making Informed Choices - Part 2</title>
      <description><![CDATA[Date: February 26, 2013

Speaker: Stephen D. Nimer, MD

Topics:
Understanding goals of treatment for your diagnosis
Understanding your treatment options
Benefits and risks for standard treatments and investigational treatments
Key facts about clinical trials]]></description>
      <pubDate>Fri, 05 Apr 2013 20:27:04 GMT</pubDate>
      <itunes:duration>00:14:31</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Date: February 26, 2013&#13;
&#13;
Speaker: Stephen D. Nimer, MD&#13;
&#13;
Topics:&#13;
Understanding goals of treatment for your diagnosis&#13;
Understanding your treatment options&#13;
Benefits and risks for standard treatments and investigational treatments&#13;
Key facts about clinical trials</itunes:summary>
      <itunes:subtitle>Blood Cancer Treatment - Making Informed Choices - Part 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/6fe49280-bd63-156f-1654-24aa83296fbd.mp3" type="audio/mpeg" length="3485940"/>
      <media:title>Blood Cancer Treatment - Making Informed Choices - Part 2</media:title>
      <media:text type="plain">Date: February 26, 2013&#13;
&#13;
Speaker: Stephen D. Nimer, MD&#13;
&#13;
Topics:&#13;
Understanding goals of treatment for your diagnosis&#13;
Understanding your treatment options&#13;
Benefits and risks for standard treatments and investigational treatments&#13;
Key facts about clinical trials</media:text>
      <media:content url="http://lls.hipcast.com/deluge/6fe49280-bd63-156f-1654-24aa83296fbd.mp3" type="audio/mpeg" fileSize="3485940" duration="871"/>
      <link>http://lls.hipcast.com/deluge/6fe49280-bd63-156f-1654-24aa83296fbd.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">7799ad93-4e9f-3b7e-98ac-e4cccbbd5494</guid>
      <title>Partners in Progress: An Expert Panel Discussion - Part 2</title>
      <description><![CDATA[June 22, 2010 - Part 2

Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers

This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine & Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia & Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.
 
This program was sponsored by The Leukemia & Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen.]]></description>
      <pubDate>Fri, 09 Jul 2010 16:11:58 GMT</pubDate>
      <itunes:duration>00:59:54</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>June 22, 2010 - Part 2&#13;
&#13;
Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers&#13;
&#13;
This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine &amp; Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia &amp; Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.&#13;
 &#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen.</itunes:summary>
      <itunes:subtitle>Partners in Progress: An Expert Panel Discussion - Part 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/aebb9375-46e9-19fc-8536-b44daa0d4e65.mp3" type="audio/mpeg" length="14377715"/>
      <media:title>Partners in Progress: An Expert Panel Discussion - Part 2</media:title>
      <media:text type="plain">June 22, 2010 - Part 2&#13;
&#13;
Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers&#13;
&#13;
This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine &amp; Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia &amp; Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.&#13;
 &#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/aebb9375-46e9-19fc-8536-b44daa0d4e65.mp3" type="audio/mpeg" fileSize="14377715" duration="3594"/>
      <link>http://lls.hipcast.com/deluge/aebb9375-46e9-19fc-8536-b44daa0d4e65.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">8633a608-ee89-efd0-ffa9-908ad2ba3a7e</guid>
      <title>Partners in Progress: An Expert Panel Discussion - Part 1</title>
      <description><![CDATA[June 22, 2010 - Part 1

Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers

This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine & Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia & Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.
 
This program was sponsored by The Leukemia & Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen.]]></description>
      <pubDate>Fri, 09 Jul 2010 16:11:07 GMT</pubDate>
      <itunes:duration>00:53:18</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>June 22, 2010 - Part 1&#13;
&#13;
Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers&#13;
&#13;
This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine &amp; Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia &amp; Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.&#13;
 &#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen.</itunes:summary>
      <itunes:subtitle>Partners in Progress: An Expert Panel Discussion - Part 1</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/2b92886f-90b9-50f5-3401-517ec2b923c2.mp3" type="audio/mpeg" length="12792605"/>
      <media:title>Partners in Progress: An Expert Panel Discussion - Part 1</media:title>
      <media:text type="plain">June 22, 2010 - Part 1&#13;
&#13;
Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers&#13;
&#13;
This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine &amp; Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia &amp; Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.&#13;
 &#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/2b92886f-90b9-50f5-3401-517ec2b923c2.mp3" type="audio/mpeg" fileSize="12792605" duration="3198"/>
      <link>http://lls.hipcast.com/deluge/2b92886f-90b9-50f5-3401-517ec2b923c2.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">39763536-5a02-a11a-9030-d788aad6f2d4</guid>
      <title>MDS: An Update on Diagnosis and Treatment</title>
      <description><![CDATA[May 18, 2010 - Part 2 (Q&A)

Myelodysplastic Syndromes (MDS): An Update on Diagnosis and Treatment

This program featured Stephen D. Nimer, MD, Chief, Hematology Service, Vice Chairman for Faculty Development, Department of Medicine, Alfred P. Sloan Chair, Memorial Sloan-Kettering Cancer Center, Professor of Medicine and Pharmacology at Weill Cornell Medical College in New York, NY.

This program was sponsored by The Leukemia & Lymphoma Society and was supported by a grant from Celgene Corporation.]]></description>
      <pubDate>Tue, 01 Jun 2010 20:47:21 GMT</pubDate>
      <itunes:duration>00:22:03</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>May 18, 2010 - Part 2 (Q&amp;A)&#13;
&#13;
Myelodysplastic Syndromes (MDS): An Update on Diagnosis and Treatment&#13;
&#13;
This program featured Stephen D. Nimer, MD, Chief, Hematology Service, Vice Chairman for Faculty Development, Department of Medicine, Alfred P. Sloan Chair, Memorial Sloan-Kettering Cancer Center, Professor of Medicine and Pharmacology at Weill Cornell Medical College in New York, NY.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by a grant from Celgene Corporation.</itunes:summary>
      <itunes:subtitle>Part 2 of 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/9c82a244-1da6-3429-049d-2ba8512dfd2b.mp3" type="audio/mpeg" length="5293477"/>
      <media:title>MDS: An Update on Diagnosis and Treatment</media:title>
      <media:text type="plain">May 18, 2010 - Part 2 (Q&amp;A)&#13;
&#13;
Myelodysplastic Syndromes (MDS): An Update on Diagnosis and Treatment&#13;
&#13;
This program featured Stephen D. Nimer, MD, Chief, Hematology Service, Vice Chairman for Faculty Development, Department of Medicine, Alfred P. Sloan Chair, Memorial Sloan-Kettering Cancer Center, Professor of Medicine and Pharmacology at Weill Cornell Medical College in New York, NY.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by a grant from Celgene Corporation.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/9c82a244-1da6-3429-049d-2ba8512dfd2b.mp3" type="audio/mpeg" fileSize="5293477" duration="1323"/>
      <link>http://lls.hipcast.com/deluge/9c82a244-1da6-3429-049d-2ba8512dfd2b.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">97408550-3446-1975-6088-4a7224c3ff80</guid>
      <title>MDS: An Update on Diagnosis and Treatment</title>
      <description><![CDATA[May 18, 2010 - Part 1 (Presentation)

Myelodysplastic Syndromes (MDS): An Update on Diagnosis and Treatment

This program featured Stephen D. Nimer, MD, Chief, Hematology Service, Vice Chairman for Faculty Development, Department of Medicine, Alfred P. Sloan Chair, Memorial Sloan-Kettering Cancer Center, Professor of Medicine and Pharmacology at Weill Cornell Medical College in New York, NY.

This program was sponsored by The Leukemia & Lymphoma Society and was supported by a grant from Celgene Corporation.]]></description>
      <pubDate>Tue, 01 Jun 2010 20:46:25 GMT</pubDate>
      <itunes:duration>00:35:09</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>May 18, 2010 - Part 1 (Presentation)&#13;
&#13;
Myelodysplastic Syndromes (MDS): An Update on Diagnosis and Treatment&#13;
&#13;
This program featured Stephen D. Nimer, MD, Chief, Hematology Service, Vice Chairman for Faculty Development, Department of Medicine, Alfred P. Sloan Chair, Memorial Sloan-Kettering Cancer Center, Professor of Medicine and Pharmacology at Weill Cornell Medical College in New York, NY.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by a grant from Celgene Corporation.</itunes:summary>
      <itunes:subtitle>Part 1 of 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/4b374e3d-2b0a-d5fa-477f-9d684a907612.mp3" type="audio/mpeg" length="8436425"/>
      <media:title>MDS: An Update on Diagnosis and Treatment</media:title>
      <media:text type="plain">May 18, 2010 - Part 1 (Presentation)&#13;
&#13;
Myelodysplastic Syndromes (MDS): An Update on Diagnosis and Treatment&#13;
&#13;
This program featured Stephen D. Nimer, MD, Chief, Hematology Service, Vice Chairman for Faculty Development, Department of Medicine, Alfred P. Sloan Chair, Memorial Sloan-Kettering Cancer Center, Professor of Medicine and Pharmacology at Weill Cornell Medical College in New York, NY.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by a grant from Celgene Corporation.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/4b374e3d-2b0a-d5fa-477f-9d684a907612.mp3" type="audio/mpeg" fileSize="8436425" duration="2109"/>
      <link>http://lls.hipcast.com/deluge/4b374e3d-2b0a-d5fa-477f-9d684a907612.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">a8c6b58a-bcca-cb56-1f9d-8eda0d0aec02</guid>
      <title>MDS: Exploring Current and Emerging Therapies - Part 2</title>
      <description><![CDATA[March 26, 2009 - Part 2 (Q&A)

Myelodysplastic Syndromes (MDS): Exploring Current and Emerging Therapies

This program featured Alan F. List, MD., Executive Vice President, Physician-in-Chief & The Frank and Carol Morsani Endowed Chair, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

This program was sponsored by The Leukemia & Lymphoma Society and was supported by Celgene.

For other archived MDS programs visit: http://www.leukemia-lymphoma.org/all_page?item_id=557515]]></description>
      <pubDate>Thu, 23 Apr 2009 20:41:32 GMT</pubDate>
      <itunes:duration>00:38:02</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>March 26, 2009 - Part 2 (Q&amp;A)&#13;
&#13;
Myelodysplastic Syndromes (MDS): Exploring Current and Emerging Therapies&#13;
&#13;
This program featured Alan F. List, MD., Executive Vice President, Physician-in-Chief &amp; The Frank and Carol Morsani Endowed Chair, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by Celgene.&#13;
&#13;
For other archived MDS programs visit: http://www.leukemia-lymphoma.org/all_page?item_id=557515</itunes:summary>
      <itunes:subtitle>MDS: Exploring Current and Emerging Therapies - Part 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/e04e320c-9391-0f67-b3e7-287643382ac8.mp3" type="audio/mpeg" length="9127939"/>
      <media:title>MDS: Exploring Current and Emerging Therapies - Part 2</media:title>
      <media:text type="plain">March 26, 2009 - Part 2 (Q&amp;A)&#13;
&#13;
Myelodysplastic Syndromes (MDS): Exploring Current and Emerging Therapies&#13;
&#13;
This program featured Alan F. List, MD., Executive Vice President, Physician-in-Chief &amp; The Frank and Carol Morsani Endowed Chair, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by Celgene.&#13;
&#13;
For other archived MDS programs visit: http://www.leukemia-lymphoma.org/all_page?item_id=557515</media:text>
      <media:content url="http://lls.hipcast.com/deluge/e04e320c-9391-0f67-b3e7-287643382ac8.mp3" type="audio/mpeg" fileSize="9127939" duration="2282"/>
      <link>http://lls.hipcast.com/deluge/e04e320c-9391-0f67-b3e7-287643382ac8.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">caf4b823-f395-b846-c791-218529e869f5</guid>
      <title>MDS: Exploring Current and Emerging Therapies - Part 1</title>
      <description><![CDATA[March 26, 2009 - Part 1 (Presentation)

Myelodysplastic Syndromes (MDS): Exploring Current and Emerging Therapies

This program featured Alan F. List, MD., Executive Vice President, Physician-in-Chief & The Frank and Carol Morsani Endowed Chair, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

This program was sponsored by The Leukemia & Lymphoma Society and was supported by Celgene.

For other archived MDS programs visit: http://www.leukemia-lymphoma.org/all_page?item_id=557515]]></description>
      <pubDate>Thu, 23 Apr 2009 20:40:31 GMT</pubDate>
      <itunes:duration>00:42:29</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>March 26, 2009 - Part 1 (Presentation)&#13;
&#13;
Myelodysplastic Syndromes (MDS): Exploring Current and Emerging Therapies&#13;
&#13;
This program featured Alan F. List, MD., Executive Vice President, Physician-in-Chief &amp; The Frank and Carol Morsani Endowed Chair, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by Celgene.&#13;
&#13;
For other archived MDS programs visit: http://www.leukemia-lymphoma.org/all_page?item_id=557515</itunes:summary>
      <itunes:subtitle>MDS: Exploring Current and Emerging Therapies - Part 1</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/8a08929f-1661-faa0-a937-9d09851ef07d.mp3" type="audio/mpeg" length="10195929"/>
      <media:title>MDS: Exploring Current and Emerging Therapies - Part 1</media:title>
      <media:text type="plain">March 26, 2009 - Part 1 (Presentation)&#13;
&#13;
Myelodysplastic Syndromes (MDS): Exploring Current and Emerging Therapies&#13;
&#13;
This program featured Alan F. List, MD., Executive Vice President, Physician-in-Chief &amp; The Frank and Carol Morsani Endowed Chair, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by Celgene.&#13;
&#13;
For other archived MDS programs visit: http://www.leukemia-lymphoma.org/all_page?item_id=557515</media:text>
      <media:content url="http://lls.hipcast.com/deluge/8a08929f-1661-faa0-a937-9d09851ef07d.mp3" type="audio/mpeg" fileSize="10195929" duration="2549"/>
      <link>http://lls.hipcast.com/deluge/8a08929f-1661-faa0-a937-9d09851ef07d.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">a1d38514-3cf5-ec60-386a-cd870f9ff163</guid>
      <title>Stem Cell Transplantation: Current Trends/Future Directions</title>
      <description><![CDATA[2/21/2008

This program featured Armand Keating, MD, FRCP(C), Professor of Medicine, Director, Division of Hematology, Epstein Chair in Cell Therapy and Transplantation at the University of Toronto.  Director, Cell Therapy Program at Princess Margaret Hospital/Ontario Cancer Institute in Toronto, Ontario, Canada.

This program was sponsored by The Leukemia and Lymphoma Society.

Click here for the direct link to the audio:
http://lls.hipcast.com/deluge/c940160b-5502-04f4-cb52-949b96782aaf.mp3]]></description>
      <pubDate>Mon, 05 May 2008 16:03:30 GMT</pubDate>
      <itunes:duration>00:58:44</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>2/21/2008&#13;
&#13;
This program featured Armand Keating, MD, FRCP(C), Professor of Medicine, Director, Division of Hematology, Epstein Chair in Cell Therapy and Transplantation at the University of Toronto.  Director, Cell Therapy Program at Princess Margaret Hospital/Ontario Cancer Institute in Toronto, Ontario, Canada.&#13;
&#13;
This program was sponsored by The Leukemia and Lymphoma Society.&#13;
&#13;
Click here for the direct link to the audio:&#13;
http://lls.hipcast.com/deluge/c940160b-5502-04f4-cb52-949b96782aaf.mp3</itunes:summary>
      <itunes:subtitle>Stem Cell Transplantation: Current Trends/Future Directions</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/c940160b-5502-04f4-cb52-949b96782aaf.mp3" type="audio/mpeg" length="14097369"/>
      <media:title>Stem Cell Transplantation: Current Trends/Future Directions</media:title>
      <media:text type="plain">2/21/2008&#13;
&#13;
This program featured Armand Keating, MD, FRCP(C), Professor of Medicine, Director, Division of Hematology, Epstein Chair in Cell Therapy and Transplantation at the University of Toronto.  Director, Cell Therapy Program at Princess Margaret Hospital/Ontario Cancer Institute in Toronto, Ontario, Canada.&#13;
&#13;
This program was sponsored by The Leukemia and Lymphoma Society.&#13;
&#13;
Click here for the direct link to the audio:&#13;
http://lls.hipcast.com/deluge/c940160b-5502-04f4-cb52-949b96782aaf.mp3</media:text>
      <media:content url="http://lls.hipcast.com/deluge/c940160b-5502-04f4-cb52-949b96782aaf.mp3" type="audio/mpeg" fileSize="14097369" duration="3524"/>
      <link>http://lls.hipcast.com/deluge/c940160b-5502-04f4-cb52-949b96782aaf.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">5df297ae-b190-e904-0599-f6c4f4678b14</guid>
      <title>Myelodysplastic Syndromes-Therapies and Treatment Options 2</title>
      <description><![CDATA[10/26/05

Part 2 of 2. The program featured Steven D. Gore, M.D., Johns Hopkins University School of Medicine, Baltimore; and Elihu Estey, M.D., The University of Texas M.D. Anderson Cancer Center, Houston.

This program was sponsored by The Leukemia & Lymphoma Society in collaboration with educational grants from Celgene and Pharmion.

Alternate link to the audio:
http://lls.audioblog.com/download/70922bcd-8a90-c37d-5d98-4efe285acaa4.mp3]]></description>
      <pubDate>Tue, 26 Feb 2008 20:53:53 GMT</pubDate>
      <itunes:duration>00:52:06</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>10/26/05&#13;
&#13;
Part 2 of 2. The program featured Steven D. Gore, M.D., Johns Hopkins University School of Medicine, Baltimore; and Elihu Estey, M.D., The University of Texas M.D. Anderson Cancer Center, Houston.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society in collaboration with educational grants from Celgene and Pharmion.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.audioblog.com/download/70922bcd-8a90-c37d-5d98-4efe285acaa4.mp3</itunes:summary>
      <itunes:subtitle>Myelodysplastic Syndromes-Therapies and Treatment Options 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/70922bcd-8a90-c37d-5d98-4efe285acaa4.mp3" type="audio/mpeg" length="12503133"/>
      <media:title>Myelodysplastic Syndromes-Therapies and Treatment Options 2</media:title>
      <media:text type="plain">10/26/05&#13;
&#13;
Part 2 of 2. The program featured Steven D. Gore, M.D., Johns Hopkins University School of Medicine, Baltimore; and Elihu Estey, M.D., The University of Texas M.D. Anderson Cancer Center, Houston.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society in collaboration with educational grants from Celgene and Pharmion.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.audioblog.com/download/70922bcd-8a90-c37d-5d98-4efe285acaa4.mp3</media:text>
      <media:content url="http://lls.hipcast.com/deluge/70922bcd-8a90-c37d-5d98-4efe285acaa4.mp3" type="audio/mpeg" fileSize="12503133" duration="3126"/>
      <link>http://lls.hipcast.com/deluge/70922bcd-8a90-c37d-5d98-4efe285acaa4.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">0f06d851-f7dd-acd4-f82b-4c51df0e2494</guid>
      <title>Myelodysplastic Syndromes:Therapies &amp; Transplant Options (1)</title>
      <description><![CDATA[10/26/05

Part 1 of 2. The program featured Steven D. Gore, M.D., Johns Hopkins University School of Medicine, Baltimore; and Elihu Estey, M.D., The University of Texas M.D. Anderson Cancer Center, Houston.

This program was sponsored by The Leukemia & Lymphoma Society in collaboration with educational grants from Celgene and Pharmion. 

Alternate link to the audio:
http://lls.audioblog.com/download/59f4eb73-4557-8876-7292-6d5a8c61fcdc.mp3]]></description>
      <pubDate>Tue, 26 Feb 2008 20:53:24 GMT</pubDate>
      <itunes:duration>00:45:28</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>10/26/05&#13;
&#13;
Part 1 of 2. The program featured Steven D. Gore, M.D., Johns Hopkins University School of Medicine, Baltimore; and Elihu Estey, M.D., The University of Texas M.D. Anderson Cancer Center, Houston.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society in collaboration with educational grants from Celgene and Pharmion. &#13;
&#13;
Alternate link to the audio:&#13;
http://lls.audioblog.com/download/59f4eb73-4557-8876-7292-6d5a8c61fcdc.mp3</itunes:summary>
      <itunes:subtitle>Myelodysplastic Syndromes:Therapies &amp; Transplant Options (1)</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/59f4eb73-4557-8876-7292-6d5a8c61fcdc.mp3" type="audio/mpeg" length="10913949"/>
      <media:title>Myelodysplastic Syndromes:Therapies &amp; Transplant Options (1)</media:title>
      <media:text type="plain">10/26/05&#13;
&#13;
Part 1 of 2. The program featured Steven D. Gore, M.D., Johns Hopkins University School of Medicine, Baltimore; and Elihu Estey, M.D., The University of Texas M.D. Anderson Cancer Center, Houston.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society in collaboration with educational grants from Celgene and Pharmion. &#13;
&#13;
Alternate link to the audio:&#13;
http://lls.audioblog.com/download/59f4eb73-4557-8876-7292-6d5a8c61fcdc.mp3</media:text>
      <media:content url="http://lls.hipcast.com/deluge/59f4eb73-4557-8876-7292-6d5a8c61fcdc.mp3" type="audio/mpeg" fileSize="10913949" duration="2728"/>
      <link>http://lls.hipcast.com/deluge/59f4eb73-4557-8876-7292-6d5a8c61fcdc.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">1c3f5ae9-9586-dc1d-1601-b14aab56c374</guid>
      <title>Stem Cell Transplantation: Making an Informed Choice</title>
      <description><![CDATA[02/02/06

This free telephone education program took place on Thursday, Feb. 2, 2006. The program featured Armand Keating, M.D., professor and head, Department of Medical Oncology and Hematology Princess Margaret Hospital/Ontario Cancer Institute, Toronto, ON. 

This program was sponsored by The Leukemia & Lymphoma Society in collaboration with the National Marrow Donor Program and was supported through an educational grant from Amgen. 

Alternate link to the audio:
http://lls.audioblog.com/download/ae0dbca9-5f01-41fc-611e-988904a27e65.mp3]]></description>
      <pubDate>Tue, 26 Feb 2008 20:51:38 GMT</pubDate>
      <itunes:duration>00:51:01</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>02/02/06&#13;
&#13;
This free telephone education program took place on Thursday, Feb. 2, 2006. The program featured Armand Keating, M.D., professor and head, Department of Medical Oncology and Hematology Princess Margaret Hospital/Ontario Cancer Institute, Toronto, ON. &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society in collaboration with the National Marrow Donor Program and was supported through an educational grant from Amgen. &#13;
&#13;
Alternate link to the audio:&#13;
http://lls.audioblog.com/download/ae0dbca9-5f01-41fc-611e-988904a27e65.mp3</itunes:summary>
      <itunes:subtitle>Stem Cell Transplantation: Making an Informed Choice</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/ae0dbca9-5f01-41fc-611e-988904a27e65.mp3" type="audio/mpeg" length="12244226"/>
      <media:title>Stem Cell Transplantation: Making an Informed Choice</media:title>
      <media:text type="plain">02/02/06&#13;
&#13;
This free telephone education program took place on Thursday, Feb. 2, 2006. The program featured Armand Keating, M.D., professor and head, Department of Medical Oncology and Hematology Princess Margaret Hospital/Ontario Cancer Institute, Toronto, ON. &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society in collaboration with the National Marrow Donor Program and was supported through an educational grant from Amgen. &#13;
&#13;
Alternate link to the audio:&#13;
http://lls.audioblog.com/download/ae0dbca9-5f01-41fc-611e-988904a27e65.mp3</media:text>
      <media:content url="http://lls.hipcast.com/deluge/ae0dbca9-5f01-41fc-611e-988904a27e65.mp3" type="audio/mpeg" fileSize="12244226" duration="3061"/>
      <link>http://lls.hipcast.com/deluge/ae0dbca9-5f01-41fc-611e-988904a27e65.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">0c475e77-6d9e-7882-57b1-45c3c99afd4a</guid>
      <title>Myelodysplastic Syndromes- Latest Advances and Treatment</title>
      <description><![CDATA[11/16/06

This program featured Steven D. Gore, M.D., associate professor of Oncology at the Johns Hopkins University School of Medicine and Richard M. Stone, M.D., clinical director, Adult Leukemia Program at Dana-Farber Cancer Institute and associate professor of medicine at Harvard Medical School.  

This program was sponsored by The Leukemia & Lymphoma Society and was supported by Celgene and Pharmion.

Alternate link to the audio:
http://lls.hipcast.com/download/84d4eb82-2850-1295-e9b8-8b3f343dad0e.mp3]]></description>
      <pubDate>Tue, 26 Feb 2008 20:50:35 GMT</pubDate>
      <itunes:duration>01:55:42</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>11/16/06&#13;
&#13;
This program featured Steven D. Gore, M.D., associate professor of Oncology at the Johns Hopkins University School of Medicine and Richard M. Stone, M.D., clinical director, Adult Leukemia Program at Dana-Farber Cancer Institute and associate professor of medicine at Harvard Medical School.  &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by Celgene and Pharmion.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/84d4eb82-2850-1295-e9b8-8b3f343dad0e.mp3</itunes:summary>
      <itunes:subtitle>Myelodysplastic Syndromes- Latest Advances and Treatment</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/84d4eb82-2850-1295-e9b8-8b3f343dad0e.mp3" type="audio/mpeg" length="27768433"/>
      <media:title>Myelodysplastic Syndromes- Latest Advances and Treatment</media:title>
      <media:text type="plain">11/16/06&#13;
&#13;
This program featured Steven D. Gore, M.D., associate professor of Oncology at the Johns Hopkins University School of Medicine and Richard M. Stone, M.D., clinical director, Adult Leukemia Program at Dana-Farber Cancer Institute and associate professor of medicine at Harvard Medical School.  &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by Celgene and Pharmion.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/84d4eb82-2850-1295-e9b8-8b3f343dad0e.mp3</media:text>
      <media:content url="http://lls.hipcast.com/deluge/84d4eb82-2850-1295-e9b8-8b3f343dad0e.mp3" type="audio/mpeg" fileSize="27768433" duration="6942"/>
      <link>http://lls.hipcast.com/deluge/84d4eb82-2850-1295-e9b8-8b3f343dad0e.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">41735d1a-6cad-6345-e0f4-2d0b8f233df5</guid>
      <title>New Perspectives on Stem Cell Transplantation</title>
      <description><![CDATA[06/21/07

This program featured Rainer F. Storb, M.D., head, Transplantation Biology Program at the Fred Hutchinson Cancer Research Program in Seattle, WA.   

Alternate link to the audio:
http://lls.hipcast.com/download/f872eaf3-1682-a5f7-9569-935f7133162c.mp3]]></description>
      <pubDate>Tue, 26 Feb 2008 20:49:47 GMT</pubDate>
      <itunes:duration>00:53:40</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>06/21/07&#13;
&#13;
This program featured Rainer F. Storb, M.D., head, Transplantation Biology Program at the Fred Hutchinson Cancer Research Program in Seattle, WA.   &#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/f872eaf3-1682-a5f7-9569-935f7133162c.mp3</itunes:summary>
      <itunes:subtitle>New Perspectives on Stem Cell Transplantation</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/f872eaf3-1682-a5f7-9569-935f7133162c.mp3" type="audio/mpeg" length="12880794"/>
      <media:title>New Perspectives on Stem Cell Transplantation</media:title>
      <media:text type="plain">06/21/07&#13;
&#13;
This program featured Rainer F. Storb, M.D., head, Transplantation Biology Program at the Fred Hutchinson Cancer Research Program in Seattle, WA.   &#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/f872eaf3-1682-a5f7-9569-935f7133162c.mp3</media:text>
      <media:content url="http://lls.hipcast.com/deluge/f872eaf3-1682-a5f7-9569-935f7133162c.mp3" type="audio/mpeg" fileSize="12880794" duration="3220"/>
      <link>http://lls.hipcast.com/deluge/f872eaf3-1682-a5f7-9569-935f7133162c.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">1f73840c-2d90-217a-5760-e0ae65b70fba</guid>
      <title>Practical Tips for Managing Your Finances and Insurance 2</title>
      <description><![CDATA[11/28/07

Cancer Survivorship: Practical Tips for Managing Your Financial and Insurance Issues - Part 2 Q&A Session

This program featured Beth Darnley, chief program officer, Patient Advocate Foundation, Newport News, Virginia and Anita Welborn, LMSW, director, Information Resource Center (IRC),  The Leukemia & Lymphoma Society, White Plains, NY.  

This program was sponsored by The Leukemia & Lymphoma Society.

Alternate link to the audio:
http://lls.hipcast.com/download/ad858520-9141-1dc0-83f9-d88f41c26ae8.mp3]]></description>
      <pubDate>Tue, 26 Feb 2008 20:49:09 GMT</pubDate>
      <itunes:duration>00:23:15</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>11/28/07&#13;
&#13;
Cancer Survivorship: Practical Tips for Managing Your Financial and Insurance Issues - Part 2 Q&amp;A Session&#13;
&#13;
This program featured Beth Darnley, chief program officer, Patient Advocate Foundation, Newport News, Virginia and Anita Welborn, LMSW, director, Information Resource Center (IRC),  The Leukemia &amp; Lymphoma Society, White Plains, NY.  &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/ad858520-9141-1dc0-83f9-d88f41c26ae8.mp3</itunes:summary>
      <itunes:subtitle>Practical Tips for Managing Your Finances and Insurance 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/ad858520-9141-1dc0-83f9-d88f41c26ae8.mp3" type="audio/mpeg" length="5581764"/>
      <media:title>Practical Tips for Managing Your Finances and Insurance 2</media:title>
      <media:text type="plain">11/28/07&#13;
&#13;
Cancer Survivorship: Practical Tips for Managing Your Financial and Insurance Issues - Part 2 Q&amp;A Session&#13;
&#13;
This program featured Beth Darnley, chief program officer, Patient Advocate Foundation, Newport News, Virginia and Anita Welborn, LMSW, director, Information Resource Center (IRC),  The Leukemia &amp; Lymphoma Society, White Plains, NY.  &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/ad858520-9141-1dc0-83f9-d88f41c26ae8.mp3</media:text>
      <media:content url="http://lls.hipcast.com/deluge/ad858520-9141-1dc0-83f9-d88f41c26ae8.mp3" type="audio/mpeg" fileSize="5581764" duration="1395"/>
      <link>http://lls.hipcast.com/deluge/ad858520-9141-1dc0-83f9-d88f41c26ae8.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">59cf14c4-6115-aa18-1a65-22ae90e061f2</guid>
      <title>Practical Tips for Managing Your Finances and Insurance 1</title>
      <description><![CDATA[11/28/07

Cancer Survivorship: Practical Tips for Managing Your Financial and Insurance Issues - Part 1 of 2 

This program featured Beth Darnley, chief program officer, Patient Advocate Foundation, Newport News, Virginia and Anita Welborn, LMSW, director, Information Resource Center (IRC),  The Leukemia & Lymphoma Society, White Plains, NY.  

This program was sponsored by The Leukemia & Lymphoma Society.

Alternate link to the audio:
http://lls.hipcast.com/download/2b62f7e8-7e73-ab61-88c1-70c8794e4aca.mp3]]></description>
      <pubDate>Tue, 26 Feb 2008 20:48:40 GMT</pubDate>
      <itunes:duration>00:34:01</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>11/28/07&#13;
&#13;
Cancer Survivorship: Practical Tips for Managing Your Financial and Insurance Issues - Part 1 of 2 &#13;
&#13;
This program featured Beth Darnley, chief program officer, Patient Advocate Foundation, Newport News, Virginia and Anita Welborn, LMSW, director, Information Resource Center (IRC),  The Leukemia &amp; Lymphoma Society, White Plains, NY.  &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/2b62f7e8-7e73-ab61-88c1-70c8794e4aca.mp3</itunes:summary>
      <itunes:subtitle>Practical Tips for Managing Your Finances and Insurance 1</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/2b62f7e8-7e73-ab61-88c1-70c8794e4aca.mp3" type="audio/mpeg" length="8164961"/>
      <media:title>Practical Tips for Managing Your Finances and Insurance 1</media:title>
      <media:text type="plain">11/28/07&#13;
&#13;
Cancer Survivorship: Practical Tips for Managing Your Financial and Insurance Issues - Part 1 of 2 &#13;
&#13;
This program featured Beth Darnley, chief program officer, Patient Advocate Foundation, Newport News, Virginia and Anita Welborn, LMSW, director, Information Resource Center (IRC),  The Leukemia &amp; Lymphoma Society, White Plains, NY.  &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/2b62f7e8-7e73-ab61-88c1-70c8794e4aca.mp3</media:text>
      <media:content url="http://lls.hipcast.com/deluge/2b62f7e8-7e73-ab61-88c1-70c8794e4aca.mp3" type="audio/mpeg" fileSize="8164961" duration="2041"/>
      <link>http://lls.hipcast.com/deluge/2b62f7e8-7e73-ab61-88c1-70c8794e4aca.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">4ffc9ec1-5ec2-702e-2cce-6cd9c20933a7</guid>
      <title>An Update on Myelodysplastic Syndromes (MDS) -  Part 2</title>
      <description><![CDATA[11/27/07

Part Two of this discussion is the Q&A portion.

This program featured Richard M. Stone, M.D., clinical director, Adult Leukemia Program, Dana-Farber Cancer Institute, attending physician, Brigham and Women's Hospital, associate professor of medicine, Harvard Medical School, Boston, MA  and Janice L. Gabrilove, M.D., vice chair, Department of Medicine, James F. Holland, professor of medicine, Mount Sinai School of Medicine, New York, NY.

This program was sponsored by The Leukemia & Lymphoma Society and supported by Celgene and Pharmion

Alternate link to the audio:
http://lls.hipcast.com/download/7cbd21fd-80bd-7bc9-cf81-1ba818eaa7ca.mp3]]></description>
      <pubDate>Tue, 26 Feb 2008 19:24:05 GMT</pubDate>
      <itunes:duration>00:58:24</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>11/27/07&#13;
&#13;
Part Two of this discussion is the Q&amp;A portion.&#13;
&#13;
This program featured Richard M. Stone, M.D., clinical director, Adult Leukemia Program, Dana-Farber Cancer Institute, attending physician, Brigham and Women's Hospital, associate professor of medicine, Harvard Medical School, Boston, MA  and Janice L. Gabrilove, M.D., vice chair, Department of Medicine, James F. Holland, professor of medicine, Mount Sinai School of Medicine, New York, NY.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by Celgene and Pharmion&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/7cbd21fd-80bd-7bc9-cf81-1ba818eaa7ca.mp3</itunes:summary>
      <itunes:subtitle>An Update on Myelodysplastic Syndromes (MDS) -  Part 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/7cbd21fd-80bd-7bc9-cf81-1ba818eaa7ca.mp3" type="audio/mpeg" length="14018166"/>
      <media:title>An Update on Myelodysplastic Syndromes (MDS) -  Part 2</media:title>
      <media:text type="plain">11/27/07&#13;
&#13;
Part Two of this discussion is the Q&amp;A portion.&#13;
&#13;
This program featured Richard M. Stone, M.D., clinical director, Adult Leukemia Program, Dana-Farber Cancer Institute, attending physician, Brigham and Women's Hospital, associate professor of medicine, Harvard Medical School, Boston, MA  and Janice L. Gabrilove, M.D., vice chair, Department of Medicine, James F. Holland, professor of medicine, Mount Sinai School of Medicine, New York, NY.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by Celgene and Pharmion&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/7cbd21fd-80bd-7bc9-cf81-1ba818eaa7ca.mp3</media:text>
      <media:content url="http://lls.hipcast.com/deluge/7cbd21fd-80bd-7bc9-cf81-1ba818eaa7ca.mp3" type="audio/mpeg" fileSize="14018166" duration="3504"/>
      <link>http://lls.hipcast.com/deluge/7cbd21fd-80bd-7bc9-cf81-1ba818eaa7ca.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">2ec2da55-667c-8980-ed8f-511bac8e4dd5</guid>
      <title>An Update on Myelodysplastic Syndromes (MDS)</title>
      <description><![CDATA[11/28/07

This program featured Richard M. Stone, M.D., clinical director, Adult Leukemia Program, Dana-Farber Cancer Institute, attending physician, Brigham and Women's Hospital, associate professor of medicine, Harvard Medical School, Boston, MA  and Janice L. Gabrilove, M.D., vice chair, Department of Medicine, James F. Holland, professor of medicine, Mount Sinai School of Medicine, New York, NY.

This program was sponsored by The Leukemia & Lymphoma Society and supported by Celgene and Pharmion

Alternate link to the audio:
http://lls.hipcast.com/download/0c1bd686-9b2d-0239-dd9e-e85f547f2096.mp3]]></description>
      <pubDate>Tue, 26 Feb 2008 19:23:25 GMT</pubDate>
      <itunes:duration>00:50:43</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>11/28/07&#13;
&#13;
This program featured Richard M. Stone, M.D., clinical director, Adult Leukemia Program, Dana-Farber Cancer Institute, attending physician, Brigham and Women's Hospital, associate professor of medicine, Harvard Medical School, Boston, MA  and Janice L. Gabrilove, M.D., vice chair, Department of Medicine, James F. Holland, professor of medicine, Mount Sinai School of Medicine, New York, NY.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by Celgene and Pharmion&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/0c1bd686-9b2d-0239-dd9e-e85f547f2096.mp3</itunes:summary>
      <itunes:subtitle>An Update on Myelodysplastic Syndromes (MDS)</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/0c1bd686-9b2d-0239-dd9e-e85f547f2096.mp3" type="audio/mpeg" length="12172562"/>
      <media:title>An Update on Myelodysplastic Syndromes (MDS)</media:title>
      <media:text type="plain">11/28/07&#13;
&#13;
This program featured Richard M. Stone, M.D., clinical director, Adult Leukemia Program, Dana-Farber Cancer Institute, attending physician, Brigham and Women's Hospital, associate professor of medicine, Harvard Medical School, Boston, MA  and Janice L. Gabrilove, M.D., vice chair, Department of Medicine, James F. Holland, professor of medicine, Mount Sinai School of Medicine, New York, NY.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by Celgene and Pharmion&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/0c1bd686-9b2d-0239-dd9e-e85f547f2096.mp3</media:text>
      <media:content url="http://lls.hipcast.com/deluge/0c1bd686-9b2d-0239-dd9e-e85f547f2096.mp3" type="audio/mpeg" fileSize="12172562" duration="3043"/>
      <link>http://lls.hipcast.com/deluge/0c1bd686-9b2d-0239-dd9e-e85f547f2096.mp3</link>
    </item>
  </channel>
</rss>
